In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease.

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

AXS-05 was well-tolerated and significantly delayed the time to agitation relapse compared with placebo in patients with ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

Sleep in midlife is a bear for many, but University of California researchers found an important link when the issue ...

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be ...

Calcium transport into and out of mitochondria is central to cellular energy production and cell death. To maintain the ...

Not spending enough time in the two deep stages of sleep — slow-wave and rapid eye movement, or REM, sleep — may hasten the ...